Coverage
Filings
Danish biosolutions company Novonesis on Thursday raised its full-year sales forecast after reporting strong growth for the first nine months of the year, citing a robust performance across its markets.
Novonesis on Wednesday laid out new long-term financial targets, aiming to accelerate sales growth and expand profit margins through 2030 as part of its new ‘GROW’ strategy.
Novonesis has successfully completed its acquisition of dsm-firmenich's share of the Feed Enzyme Alliance, the company announced.
| 1 Feb 2013 |
| Election of employee representatives to the Board of Directors of Novozymes A/S | 1 Feb 2013 |
| Novozymes acquires enzyme business from Canadian Iogen Corporation | 31 Jan 2013 |
| The Novozymes report 2012 | 23 Jan 2013 |
| New Novozymes President & CEO: Peder Holk Nielsen | 21 Jan 2013 |